Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Esophageal Squamous Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06747585
What this trial is testing

Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors

Who this might be right for
Squamous Non-small-cell Lung CancerHead and Neck Squamous Cell CarcinomaCervical Squamous Cell Carcinoma+1 more
Alentis Therapeutics AG 170
Very early researchStudy completedNCT01384708
What this trial is testing

Evaluation of a Miniaturized Microscope Device for the Detection of Esophageal Squamous Cell Cancer

Who this might be right for
Squamous Cell Cancer
Anandasabapathy, Sharmila, M.D. 70
Not applicableLooking for participantsNCT06169163
What this trial is testing

Volatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal Neoplasms

Who this might be right for
Oesophageal Squamous Cell CarcinomaOesophageal Cancer
Imperial College London 518
Large-scale testing (Phase 3)Not Yet RecruitingNCT05244798
What this trial is testing

Sintilimab Plus NCT or NCRT Versus NCRT for ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sichuan Cancer Hospital and Research Institute 420
Testing effectiveness (Phase 2)Looking for participantsNCT07733830
What this trial is testing

Comparing ICI Followed By CCRT And CCRT Followed By Immunotherapy In Unresectable LA-ESCC

Who this might be right for
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06178211
What this trial is testing

Neoadjuvant Adebrelimab Plus Chemotherapy for Resectable ESCC: a Single Arm, Prospective Phase 2 Clinical Trial

Who this might be right for
Esophageal Squamous Cell Carcinoma
Shanghai Chest Hospital 36
Testing effectiveness (Phase 2)Ended earlyNCT00064259
What this trial is testing

A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+11 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)UnknownNCT03913182
What this trial is testing

Apatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell CarcinomaApatinibRecurrence+1 more
Shanghai Chest Hospital 39
Early research (Phase 1)Ended earlyNCT01249443
What this trial is testing

Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection

Who this might be right for
HIV InfectionRecurrent Anal CancerRecurrent Breast Cancer+31 more
AIDS Malignancy Consortium 17
Testing effectiveness (Phase 2)UnknownNCT03940976
What this trial is testing

Afatinib in Previously Treated ESCC With EGFR Overexpression or EGFR Amplification (ESCC-A01)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking University 40
Testing effectiveness (Phase 2)Study completedNCT00003055
What this trial is testing

Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT04764240
What this trial is testing

Precisely Estimation of the Prognostic Value of Lymph Node in ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Shanghai Cancer Hospital, China 3,700
Testing effectiveness (Phase 2)UnknownNCT00915850
What this trial is testing

Trial of Docetaxel, Cisplatin, Fluorouracil (5-FU) for Unresectable Advanced Esophageal Squamous Cell Carcinoma (ESCC)

Who this might be right for
Esophageal Cancer
Wakayama Medical University 32
Testing effectiveness (Phase 2)UnknownNCT05547828
What this trial is testing

Efficacy and Safety of Tislelizumab and Nab-paclitaxel Combined With Low-dose Radiotherapy in Patients With Stage IVb Esophageal Squamous Cell Carcinoma

Who this might be right for
ESCC
The First Affiliated Hospital of Xinxiang Medical College 20
Testing effectiveness (Phase 2)Study completedNCT03322267
What this trial is testing

Adjuvant Pembrolizumab for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma at High Risk of Recurrence

Who this might be right for
Esophageal Squamous Cell Carcinoma
National Taiwan University Hospital 26
Testing effectiveness (Phase 2)Study completedNCT00002984
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
UNC Lineberger Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Looking for participantsNCT05182944
What this trial is testing

Perioperative Camrelizumab Combined With Chemotherapy in Patients With Resectable ESCC

Who this might be right for
Esophageal Cancer
The First Affiliated Hospital of Zhengzhou University 130
Large-scale testing (Phase 3)Active Not RecruitingNCT05043688
What this trial is testing

Camrelizumab Plus Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Chemoradiotherapy in Resectable ESCC.

Who this might be right for
Resectable Esophageal Squamous Cell Carcinoma
Zhigang Li 426
Testing effectiveness (Phase 2)Study completedNCT03925870
What this trial is testing

KN046 in Subjects With Late Stage Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT07711470
What this trial is testing

Phase II Study of Induction Chemoimmunotherapy Followed by Radiotherapy and Organ Preservation in Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 140
Next Page